Untitled-design-2023-09-02T073833.101-1.jpg

Will Moderna Stock Recover?

The global impacts of COVID-19 are finally easing. But in spite of the damage the pandemic inflicted on the economy at large, some companies directly benefited …

Untitled-design-2023-06-27T103116.508.jpg

Best Stocks to Invest $50,000 Right Now

Uncovering the right stocks to channel your hard-earned resources into can be an exciting and daunting challenge. However, if you have $50,000 to hand, you …

Untitled-design-2023-04-14T124203.382.jpg

Where Will Moderna Stock Be In 1 Year?

Moderna (MRNA) stock experienced exponential growth over the past few years due to profits and publicity from its coronavirus vaccine. As the demand for …

Untitled-design-2023-01-10T213613.703.jpg

Why Did CureVac Stock Go Up?

CureVac is a German biotechnology company that specializes in the development of messenger RNA (mRNA) vaccines and therapies. CureVac has been focused on using …

Untitled-design-2022-12-17T103542.741.jpg

Is It A Good Time To Buy Moderna Stock?

Moderna (NASDAQ:MRNA) rocketed to prominence at the height of the COVID-19 pandemic as an early developer of a vaccine against the coronavirus.   Since …

Untitled-design-2022-10-25T214106.359.jpg

Moderna vs Teladoc Stock: Which Is Best?

Moderna vs Teladoc Stock: The booming pre-COVID economy is gone, and a growing number of experts suggest that a recession is inevitable. However, despite this …

Untitled-design-2022-09-03T155939.194.jpg

2 Extremely Safe Dividend Stocks

In the investment world, it seems that the slow and steady approach always wins the race. Indeed, a reliable business with a rock-solid dividend is practically …

Untitled-design-2022-05-26T063331.274.jpg

Teladoc Plunged 81%…Time to Buy?

March 2020. Worldwide stay-at-home orders. The worst public health crisis since 1918’s Spanish Flu outbreak. Though the world was on lockdown, it didn’t …

Untitled-design-2022-05-03T090623.782.jpg

2 Biotech Stocks To Hold For 10 Years

The biotech sector suffered a mixed run of fortunes lately. While some industry stalwarts, like Pfizer, Stryker, and Roche, are down double digits this year, …

Untitled-design-2022-04-18T090917.899.jpg

1 Gene Therapy Biotech Grew 1,296%

Biotech firms can be a risky bet at the best of times, but when they do pay off they deliver the goods in a way that few other businesses can match. Take …